Skip to content

Clinical trials

Completed Schizophrenia, Treatment-Resistant trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia, Treatment-Resistant Status: Completed Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20081
20111
20121
20131
20151
20162
20172
20192
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
All India Institute of Medical Sciences, Bhubaneswar2
Centre for Addiction and Mental Health2
Ciusss de L'Est de l'Île de Montréal2
Azur Pharma, Inc1
Centre hospitalier de Ville-Evrard, France1
Daniel Benjamin1
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau1
Hospital de Clinicas de Porto Alegre1
Mersey Care NHS Trust1
National Health Research Institutes, Taiwan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia, Treatment-Resistant16
Schizophrenia9
Hallucinations5
Psychotic Disorders2
Sialorrhea2
Adenoviridae Infections1
Anxiety Disorders1
Arrhythmias, Cardiac1
Autistic Disorder1
Bipolar Disorder1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.